Geriatric factors analyses from FFCD 2001-02 phase III study of first-line chemotherapy for elderly metastatic colorectal cancer patients
Authors:
- Thomas AparicioTAThomas Aparicio
- Dany GargotDGDany Gargot
- Laurent TeilletLTLaurent Teillet
- Emilie MaillardEMEmilie Maillard
- Jacques CretinJCJacques Cretin
- Christophe LocherCLChristophe Locher
- Gilles BreysacherGBGilles Breysacher
- Jean-François SeitzJSJean-François Seitz
- Mohamed GasmiMGMohamed Gasmi
- Laetitia StefaniLSLaetitia Stefani
- Mohamed RamdaniMRMohamed Ramdani
- 1 March 2017
- journal article
- research article
- Published by Elsevier in European Journal of Cancer
- Vol. 74, 98-108
Abstract
No abstract availableKeywords
Funding Information
- Ligue Contre le Cancer
This publication has 30 references indexed in Scilit:
- Colorectal cancer care in elderly patients: Unsolved issuesDigestive and Liver Disease, 2016
- Validation of a Prediction Tool for Chemotherapy Toxicity in Older Adults With CancerJournal of Clinical Oncology, 2016
- Predictors of 1-Year Mortality in a Prospective Cohort of Elderly Patients With CancerThe Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, 2015
- Bevacizumab plus capecitabine versus capecitabine alone in elderly patients with previously untreated metastatic colorectal cancer (AVEX): an open-label, randomised phase 3 trialThe Lancet Oncology, 2013
- Predictors of Early Death Risk in Older Patients Treated With First-Line Chemotherapy for CancerJournal of Clinical Oncology, 2012
- Chemotherapy options in elderly and frail patients with metastatic colorectal cancer (MRC FOCUS2): an open-label, randomised factorial trialThe Lancet, 2011
- Use of the folinic acid/5-fluorouracil/irinotecan (FOLFIRI 1) regimen in elderly patients as a first-line treatment for metastatic colorectal cancer: a Phase II studyCancer Chemotherapy and Pharmacology, 2008
- Combination of Irinotecan (CPT-11) plus 5-Fluorouracil and Leucovorin (FOLFIRI Regimen) as First Line Treatment for Elderly Patients with Metastatic Colorectal Cancer: A Phase II TrialOncology, 2005
- Irinotecan in Combination With Fluorouracil in a 48-Hour Continuous Infusion As First-Line Chemotherapy for Elderly Patients With Metastatic Colorectal Cancer: A Spanish Cooperative Group for the Treatment of Digestive Tumors StudyJournal of Clinical Oncology, 2005
- Enrollment of Older Patients in Cancer Treatment Trials in Canada: Why is Age a Barrier?Journal of Clinical Oncology, 2003